Le Lézard
Classified in: Business
Subjects: ERP, FVT

Nelnet to Announce First Quarter Results on May 8


LINCOLN, Neb., April 15, 2019 /PRNewswire/ -- Nelnet, Inc. (NYSE: NNI) today announced it will release earnings for the first quarter ended March 31, 2019, after the close of the New York Stock Exchange on Wednesday, May 8, 2019. Upon release, additional earnings information will be available at www.nelnetinvestors.com.

Learn more about Nelnet at www.nelnet.com.

(code #: nnif)

 

SOURCE Nelnet


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of AGBA Group Holding Limited - AGBA
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
Toro Taxes, the Leading Latino Tax Franchise selects Trez, to power Payroll solutions
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Provides Bi-Weekly Update on Status of Management Cease Trade Order
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
KADESTONE CAPITAL CORP. REPORTS Q4 AND FULL YEAR 2023 FINANCIAL RESULTS
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

More news about Business...


News published on and distributed by: